丹曲林钠被重新用于治疗脓毒症或感染性休克及 COVID-19 患者。
Dantrolene repurposed to treat sepsis or septic shock and COVID-19 patients.
机构信息
Department of Anaesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, USA.
出版信息
Eur Rev Med Pharmacol Sci. 2021 Apr;25(7):3136-3144. doi: 10.26355/eurrev_202104_25569.
Abstract
Disruption of intracellular Ca2+ homeostasis via excessive and pathological Ca2+ release from the endoplasmic reticulum (ER) and/or sarcoplasmic reticulum (SR) through ryanodine receptor (RyRs) Ca2+ channels play a critical role in the pathology of systemic inflammatory response syndrome (SIRS) and associated multiple organ dysfunction syndrome (MODS) in sepsis or septic shock. Dantrolene, a potent inhibitor of RyRs, is expected to ameliorate SIRS and MODS and decrease mortality in sepsis or septic shock patients. This review summarized the potential mechanisms of therapeutic effects of dantrolene in sepsis or septic shock at molecular, cell, and organ levels and provided suggestions and strategies for future clinical studies.
摘要
细胞内钙离子稳态的破坏，通过内质网（ER）和/或肌浆网（SR）中过度和病理性的钙离子释放，通过兰尼碱受体（RyRs）钙离子通道，在全身炎症反应综合征（SIRS）和相关的多器官功能障碍综合征（MODS）的病理生理学中发挥关键作用，在败血症或感染性休克中。丹曲林钠，一种 RyRs 的有效抑制剂，有望改善败血症或感染性休克中的 SIRS 和 MODS，并降低败血症或感染性休克患者的死亡率。这篇综述总结了丹曲林钠在败血症或感染性休克中在分子、细胞和器官水平上的治疗效果的潜在机制，并为未来的临床研究提供了建议和策略。
相似文献
1
Dantrolene repurposed to treat sepsis or septic shock and COVID-19 patients.丹曲林钠被重新用于治疗脓毒症或感染性休克及 COVID-19 患者。
Eur Rev Med Pharmacol Sci. 2021 Apr;25(7):3136-3144. doi: 10.26355/eurrev_202104_25569.
2
Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?能否通过恢复细胞内钙稳态，将丹曲林作为一种重新利用的药物来治疗新冠病毒肺炎患者？
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10228-10238. doi: 10.26355/eurrev_202010_23247.
3
Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors.丹曲林通过直接且特异性作用于骨骼肌兰尼碱受体来抑制肌浆网钙离子释放。
J Biol Chem. 1997 Oct 24;272(43):26965-71. doi: 10.1074/jbc.272.43.26965.
4
Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis.脓毒症低动力期心脏肌浆网中兰尼碱敏感钙释放通道的损伤及其潜在机制
Shock. 2001 Jul;16(1):33-9. doi: 10.1097/00024382-200116010-00007.
5
Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action.苯妥英钠降低心肌兰尼碱受体 2 的活性；其心脏保护作用的潜在机制。
Mol Pharmacol. 2020 Apr;97(4):250-258. doi: 10.1124/mol.119.117721. Epub 2020 Feb 3.
6
Efficient High-Throughput Screening by Endoplasmic Reticulum Ca Measurement to Identify Inhibitors of Ryanodine Receptor Ca-Release Channels.通过内质网钙测量进行高效高通量筛选，以鉴定肌醇 1,4,5-三磷酸受体钙释放通道抑制剂。
Mol Pharmacol. 2018 Jul;94(1):722-730. doi: 10.1124/mol.117.111468. Epub 2018 Apr 19.
7
Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia.丹曲林可改善大鼠脓毒症的代谢特征，并提高内毒素血症小鼠模型的存活率。
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3039-43. doi: 10.1073/pnas.91.8.3039.
8
Ryanodine receptor inhibitor dantrolene reduces hypoxic-ischemic brain injury in neonatal mice.肌二肽受体抑制剂丹曲林钠可减轻新生小鼠缺氧缺血性脑损伤。
Exp Neurol. 2022 May;351:113985. doi: 10.1016/j.expneurol.2022.113985. Epub 2022 Jan 19.
9
Impaired sarcoplasmic calcium release inhibits myocardial contraction in experimental sepsis.肌浆网钙释放受损抑制实验性脓毒症中的心肌收缩。
J Crit Care. 2000 Jun;15(2):64-72. doi: 10.1053/jcrc.2000.7902.
10
[Altered ryanodine receptor of rat cardiac sarcoplasmic reticulum and its underlying mechanism during septic shock].[脓毒症休克时大鼠心肌肌浆网雷诺丁受体的改变及其机制]
Sheng Li Xue Bao. 1995 Aug;47(4):349-56.
引用本文的文献
1
Severe anxiety, depression, and sleep disorders worsen prognosis in patients with septic shock.严重焦虑、抑郁和睡眠障碍会使感染性休克患者的预后恶化。
World J Psychiatry. 2025 Jul 19;15(7):107038. doi: 10.5498/wjp.v15.i7.107038.
2
Neuroprotective effects of dantrolene in neurodegenerative disease: Role of inhibition of pathological inflammation.丹曲林在神经退行性疾病中的神经保护作用：抑制病理性炎症的作用
J Anesth Transl Med. 2024 Jun;3(2):27-35. doi: 10.1016/j.jatmed.2024.04.002. Epub 2024 Apr 30.
3
Optimization of CHARMM force field parameters for ryanodine receptor inhibitory drug dantrolene using FFTK and FFParam.使用 FFTK 和 FFParam 优化兰尼碱受体抑制剂丹曲林钠的 CHARMM 力场参数。
J Mol Model. 2024 Jan 23;30(2):46. doi: 10.1007/s00894-024-05841-3.
4
Risk Factors for Weaning Failure in COVID-19 Patients.新型冠状病毒肺炎患者撤机失败的危险因素
J Crit Care Med (Targu Mures). 2023 Jul 31;9(3):170-177. doi: 10.2478/jccm-2023-0021. eCollection 2023 Jul.
5
Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database.静脉注射丹曲林治疗代谢亢进综合征：美国退伍军人事务部数据库调查。
BMC Anesthesiol. 2022 Sep 19;22(1):298. doi: 10.1186/s12871-022-01841-z.
6
Screening the Potential Biomarkers of COVID-19-Related Thrombosis Through Bioinformatics Analysis.通过生物信息学分析筛选新型冠状病毒肺炎相关血栓形成的潜在生物标志物
Front Genet. 2022 May 25;13:889348. doi: 10.3389/fgene.2022.889348. eCollection 2022.
7
Could Lower Testosterone in Older Men Explain Higher COVID-19 Morbidity and Mortalities?老年男性睾丸激素水平降低是否可以解释 COVID-19 发病率和死亡率更高？
Int J Mol Sci. 2022 Jan 15;23(2):935. doi: 10.3390/ijms23020935.
本文引用的文献
1
Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report.丹曲林钠治疗 COVID-19 相关潜在迟发性并发症横纹肌溶解症的疗效：病例报告。
Eur J Med Res. 2021 Feb 8;26(1):18. doi: 10.1186/s40001-021-00489-8.
2
Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients.治疗新冠肺炎患者低氧血症的氧疗策略与技术
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10239-10246. doi: 10.26355/eurrev_202010_23248.
3
Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?能否通过恢复细胞内钙稳态，将丹曲林作为一种重新利用的药物来治疗新冠病毒肺炎患者？
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10228-10238. doi: 10.26355/eurrev_202010_23247.
4
Calpain Activation and Organ Failure in Sepsis: Molecular Insights and Therapeutic Perspectives.脓毒症中钙蛋白酶激活与器官衰竭：分子见解与治疗前景
Shock. 2021 Jul 1;56(1):5-15. doi: 10.1097/SHK.0000000000001679.
5
Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.SARS-CoV-2 引发的炎症反应和 ACE2 增强驱动严重 COVID-19 的多器官衰竭：分子机制及意义。
Inflammation. 2021 Feb;44(1):13-34. doi: 10.1007/s10753-020-01337-3. Epub 2020 Oct 8.
6
COVID-19 and multiorgan failure: A narrative review on potential mechanisms.COVID-19 与多器官衰竭：潜在机制的叙述性综述。
J Mol Histol. 2020 Dec;51(6):613-628. doi: 10.1007/s10735-020-09915-3. Epub 2020 Oct 4.
7
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?Toll 样受体 4 是否与合并心血管代谢疾病的 COVID-19 患者的病理严重程度有关？
Cytokine Growth Factor Rev. 2021 Apr;58:102-110. doi: 10.1016/j.cytogfr.2020.09.002. Epub 2020 Sep 21.
8
Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease.肌质网钙释放通道受体：多种神经退行性疾病的潜在治疗靶点
Cell Mol Neurobiol. 2021 Nov;41(8):1613-1624. doi: 10.1007/s10571-020-00936-w. Epub 2020 Aug 24.
9
Dantrolene prevents hepatic steatosis by reducing cytoplasmic Ca level and ER stress.丹曲林通过降低细胞质钙水平和内质网应激来预防肝脂肪变性。
Biochem Biophys Rep. 2020 Jul 21;23:100787. doi: 10.1016/j.bbrep.2020.100787. eCollection 2020 Sep.
10
Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.鼻腔内给予丹曲林作为阿尔茨海默病 5XFAD 小鼠的疾病修饰药物。
J Alzheimers Dis. 2020;76(4):1375-1389. doi: 10.3233/JAD-200227.
Zotero 插件